Source: Eur Respir J 2016; 48: 683-693
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vozoris Nicholas T., Wang Xuesong, Fischer Hadas D., Bell Chaim M., O'Donnell Denis E., Austin Peter C., Stephenson Anne L., Gill Sudeep S., Rochon Paula A.. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J 2016; 48: 683-693

Member's Comments

No comment yet.

Related content which might interest you: Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2015; 45: 566-567 Year: 2015 Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2014; 44: 332-340 Year: 2014 Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2015; 45: 565-566 Year: 2015 Incident opioid use is associated with risk of respiratory harm in non-palliative COPD Source: Eur Respir J , 49 (3) 1602529; DOI: 10.1183/13993003.02529-2016 Year: 2017 Serotonergic antidepressant use and morbidity and mortality among older adults with COPD Source: Eur Respir J, 52 (1) 1800475; 10.1183/13993003.00475-2018 Year: 2018 Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events Source: Eur Respir J, 49 (5) 1602245; 10.1183/13993003.02245-2016 Year: 2017 Self-care behavior for medications use and treatment outcome in elderly with asthma Source: Annual Congress 2010 - Dysfunctional breathing, asthma and respiratory physiotherapy problems Year: 2010 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Do cardiovascular drugs reduce exacerbations rates in primary care patients with COPD? Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Dyspnea sensation and health-related quality predict exacerbations, hospitalizations and mortality in patients with chronic respiratory failure receiving long-term oxygen therapy Source: Eur Respir J 2006; 28: Suppl. 50, 519s Year: 2006 Short physical performance battery as a predictor of adverse outcomes following hospitalisation for an acute exacerbation of COPD Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases Year: 2016 Long-acting beta2-agonists in adult asthma and the pattern of risk of death and severe asthma outcomes: a study using the GPRD Source: Eur Respir J 2010; 36: 494-502 Year: 2010 Smoking cessation interventions in hospitalised respiratory patients Source: Annual Congress 2007 - Nursing interventions in the prevention and management of respiratory disease Year: 2007 Pharmacological treatment of self-reported cardiovascular comorbidity in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 453s Year: 2007 Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations Source: Eur Respir Rev 2006; 15: 47-51 Year: 2006 Clinical and inhaled drug profile of COPD patients with indication for beta-blockers who are on beta-blockers Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Predictors of frequent hospitalisations for exacerbations in COPD Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003